Q2 2025 Earnings Call Transcript August 6, 2025 Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, ...

Novavax tops Q2 estimates and lifts 2025 sales forecast as Sanofi takes over global rollout of its COVID vaccine.

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...

In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...

COVID vaccines, including the new non-mRNA product Novavax, are safe and effective and decrease the burden of illness and ...

Federal vaccine policy changes under RFK Jr. have some concerned health insurance will not cover COVID shots. A bill in NY seeks to mandate coverage.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Note that some links may require registration or subscription. Experiments showed that the recommended 6 feet of social ...

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

A research study from the United States suggests that bird flu could have spread amongst cattle through the air or ...